FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

781908005: Product containing precisely gentamicin (as gentamicin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3752094016 Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3752095015 Product containing precisely gentamicin (as gentamicin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection Is a Medicinal product (product) true Inferred relationship Some
Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection Has manufactured dose form Solution for injection true Inferred relationship Some
Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection Has basis of strength substance (attribute) Gentamicin (substance) true Inferred relationship Some 1
Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection Has concentration strength denominator unit mL true Inferred relationship Some 1
Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection Has concentration strength numerator unit mg true Inferred relationship Some 1
Gentamicin (as gentamicin sulfate) 40 mg/mL solution for injection Has precise active ingredient Gentamicin sulfate true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start